CR20240094A - Composiciones estabilizadas - Google Patents
Composiciones estabilizadasInfo
- Publication number
- CR20240094A CR20240094A CR20240094A CR20240094A CR20240094A CR 20240094 A CR20240094 A CR 20240094A CR 20240094 A CR20240094 A CR 20240094A CR 20240094 A CR20240094 A CR 20240094A CR 20240094 A CR20240094 A CR 20240094A
- Authority
- CR
- Costa Rica
- Prior art keywords
- stabilized compositions
- compositions
- stabilized
- ruminants
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
- A23K40/35—Making capsules specially adapted for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
- Y02P60/22—Methane [CH4], e.g. from rice paddies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Fodder In General (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones para reducir o inhibir la metanogénesis en rumiantes que comprenden al menos un compuesto de halocarburo y uno o más agentes estabilizadores.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021902391A AU2021902391A0 (en) | 2021-08-03 | Stabilised Compositions | |
| PCT/AU2022/050836 WO2023010170A1 (en) | 2021-08-03 | 2022-08-03 | Stabilised compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20240094A true CR20240094A (es) | 2024-08-06 |
Family
ID=85154002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20240094A CR20240094A (es) | 2021-08-03 | 2022-08-03 | Composiciones estabilizadas |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240252449A1 (es) |
| EP (1) | EP4380553A4 (es) |
| JP (1) | JP2024531996A (es) |
| KR (1) | KR20240047987A (es) |
| CN (1) | CN117979961A (es) |
| AU (1) | AU2022322635A1 (es) |
| BR (1) | BR112024002182A2 (es) |
| CA (1) | CA3227523A1 (es) |
| CL (1) | CL2024000329A1 (es) |
| CO (1) | CO2024002498A2 (es) |
| CR (1) | CR20240094A (es) |
| MX (1) | MX2024001652A (es) |
| WO (1) | WO2023010170A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240146059A (ko) * | 2022-02-09 | 2024-10-07 | 퓨처피드 피티와이 리미티드 | 반추 동물에서 메탄 생산을 감소시키기 위한 신규한 조성물 |
| WO2024006531A1 (en) * | 2022-07-01 | 2024-01-04 | Arkea Bio Corp. | Compositions and methods for reducing deleterious atmospheric gas emissions from flooded ecosystems |
| US12582142B1 (en) * | 2022-08-08 | 2026-03-24 | Alga Biosciences Inc. | Feed supplements for reducing enteric methane emissions and methods thereof |
| US12599153B2 (en) | 2023-02-08 | 2026-04-14 | Rumin8 Pty Ltd | Compositions and methods for reducing greenhouse gas |
| KR20250140112A (ko) * | 2023-02-08 | 2025-09-24 | 루민8 피티와이 엘티디 | 온실 가스를 감소시키기 위한 조성물 및 방법 |
| EP4512251A1 (en) | 2023-08-23 | 2025-02-26 | Yara International ASA | Ruminant feed additive compositions having methane inhibition properties |
| WO2025220006A1 (en) | 2024-04-15 | 2025-10-23 | Bromine Compounds Ltd. | Stable solid compositions with high content of bromoform |
| WO2025228936A1 (en) * | 2024-04-29 | 2025-11-06 | Maripure Aps | Red macroalgae processing method |
| PY2535000A (es) * | 2024-05-01 | 2025-11-03 | Ruminant Biotech Corp Ltd | Forma de dosificación en bolo |
| KR102909259B1 (ko) * | 2024-09-28 | 2026-01-08 | (주) 칼리시 | 표적 물질 조절 제제 제조 방법 및 장치 |
| WO2026077952A1 (en) | 2024-10-07 | 2026-04-16 | Agteria Biotech Ab | Feed supplement for reducing methane emission by ruminant animals |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3660562A (en) * | 1970-06-24 | 1972-05-02 | Smith Kline French Lab | Method and compositions for improving feed efficiency of ruminants |
| AU463706B2 (en) * | 1972-01-21 | 1975-08-07 | Smith Kune & French Laboratories | Method and compositions for improving feed efficiency of ruminants |
| DE2203596A1 (de) * | 1972-01-26 | 1973-08-02 | Smith Kline French Lab | Oral verabreichbares praeparat zur verbesserung der futterverwertung bei wiederkaeuern und verfahren zur beeinflussung der methanbildung im pansen von wiederkaeuern |
| WO2021116395A1 (en) * | 2019-12-11 | 2021-06-17 | Dsm Ip Assets B.V. | New slow-release delivery composition |
| EP4477215A3 (en) * | 2020-12-08 | 2025-02-19 | Ruminant Biotech Corp Limited | Improvements to devices and methods for delivery of substances to animals |
| CA3205620A1 (en) * | 2020-12-21 | 2022-06-30 | Mootral Innovations Limited | Compositions for reducing methane emission, methods for improving the metabolic efficiency of ruminant animals and methanogenesis inhibitor administration |
-
2022
- 2022-08-03 BR BR112024002182A patent/BR112024002182A2/pt unknown
- 2022-08-03 CR CR20240094A patent/CR20240094A/es unknown
- 2022-08-03 CN CN202280063367.0A patent/CN117979961A/zh active Pending
- 2022-08-03 AU AU2022322635A patent/AU2022322635A1/en active Pending
- 2022-08-03 JP JP2024531556A patent/JP2024531996A/ja active Pending
- 2022-08-03 WO PCT/AU2022/050836 patent/WO2023010170A1/en not_active Ceased
- 2022-08-03 MX MX2024001652A patent/MX2024001652A/es unknown
- 2022-08-03 EP EP22851481.6A patent/EP4380553A4/en active Pending
- 2022-08-03 KR KR1020247006381A patent/KR20240047987A/ko active Pending
- 2022-08-03 CA CA3227523A patent/CA3227523A1/en active Pending
-
2024
- 2024-02-02 US US18/431,461 patent/US20240252449A1/en active Pending
- 2024-02-02 CL CL2024000329A patent/CL2024000329A1/es unknown
- 2024-02-28 CO CONC2024/0002498A patent/CO2024002498A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112024002182A2 (pt) | 2024-04-30 |
| CO2024002498A2 (es) | 2024-05-30 |
| EP4380553A4 (en) | 2025-06-25 |
| EP4380553A1 (en) | 2024-06-12 |
| CA3227523A1 (en) | 2023-02-09 |
| WO2023010170A1 (en) | 2023-02-09 |
| US20240252449A1 (en) | 2024-08-01 |
| AU2022322635A1 (en) | 2024-02-15 |
| KR20240047987A (ko) | 2024-04-12 |
| MX2024001652A (es) | 2024-05-17 |
| JP2024531996A (ja) | 2024-09-03 |
| CL2024000329A1 (es) | 2024-08-30 |
| CN117979961A (zh) | 2024-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20240094A (es) | Composiciones estabilizadas | |
| PH12020551244A1 (en) | Pd-1/pd-l1 inhibitors | |
| PH12022550469A1 (en) | Kras g12d inhibitors | |
| JOP20180039A1 (ar) | مثبطات pd-1/pd-l1 | |
| MY200356A (en) | Kras g12c inhibitors | |
| CL2019000586A1 (es) | Composiciones de toxinas clostridiales no proteicas. | |
| CL2019002609A1 (es) | Compuestos heterocíclicos útiles como inhibidores dobles atx/ca. | |
| JOP20210050B1 (ar) | معدلات تعبير pnpla3 | |
| EA201891171A1 (ru) | Стабильные композиции с инокулянтом и способы их получения | |
| PL2178504T3 (pl) | Roztwór oczny na bazie prostagladyn bez środka konserwującego | |
| BR112016002241A2 (pt) | composições de adoçante | |
| BR112018073329A2 (pt) | combinação, composição farmacêutica, kit, método para tratar câncer, método para reduzir um nível de células, método para aumentar a atividade, método para aumentar a citotoxicidade, método para reduzir metástase | |
| AR111835A1 (es) | Composiciones estables de inoculantes que comprenden aceites vegetales metilados | |
| ME01291A (me) | Derivati prikolinamida kao inhibitori kinaze | |
| MX2019008545A (es) | Estabilidad mejorada de composiciones que contienen inhibidor de la ureasa. | |
| MX2021000719A (es) | Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento. | |
| CL2008001057A1 (es) | Agente para el tratamiento de micosis producida por saprolegnia, achlya y/o aphanomyces en peces, el cual comprende al menos un fungicida seleccionado entre a) inhibidores de l a mitosis y division celular, b) inhiidores de la sintesis de ergosterol o, c) derivados de piridina, benzopiranona, carbonitrilo,quinolinas, entre otras. | |
| CL2020003010A1 (es) | Moduladores de la expresión de apol1 | |
| CL2013003307A1 (es) | Agente que comprende ciazofamida o fenamidona; y su uso para tratar micosis en peces e invertebrados en todos sus estadios de desarrollo causada por hongos de los generos saprolegnia, achlya y aphanomyces (div.sol.n°1056-08). | |
| AR059444A1 (es) | Composiciones ramnolipidicas y metodos de uso relacionados | |
| MX389692B (es) | Composiciones y métodos para promover el crecimiento del cabello con inhibidores de mpc. | |
| PH12021551435A1 (en) | Triple combination therapies for anti-aging | |
| MX394244B (es) | Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia | |
| BR112017014914A2 (pt) | terapia combinada para hipertensão pulmonar | |
| WO2017021855A3 (en) | Motile sperm domain containing protein 2 and inflammation |